Aurangabad, India site is the country’s first pharmaceutical facility, and first in Viatris’ network, to meet new British Standards Institution (BSI) Kitemark certification ... Feb 20
Latest Pharma News update... Sep 03
Sorrento intends to combine a variety of its proprietary mAbs in conjunction with the ADNAB technology platform... Apr 28
... Mar 16
The positive assessment from ANVISA reaffirms WuXi Biologics' strong commitment to offering partners a global manufacturing network of the highest standard... Dec 28
It will be the first clinical trial in China for UME treatment, and also the first one in China to adopt suprachoroidal space (SCS) injection, ... Dec 26
Royal Philips, a global leader in health technology, and InSightec, a global healthcare company today announced a collaboration to expand access to MR-guided focused ... Dec 17
Fewer species and high numbers of particular bacteria linked to heightened risk ... Dec 15
Harbour BioMed, and Utrecht University today announced that they licensed to AbbVie their fully human, SARS-CoV-2 neutralizing antibody, 47D11 and program, for the ... Dec 15
China resorts to rigorous measures after 3 cities reports fresh coronavirus cases... Nov 28
The vaccine's clinical study not only provides key data for the launch of the vaccine in China, but also may play a positive role ... Nov 25
China and WHO is discussing a trip for experts to investigate the origins of COVID-19 and the details of the trip to China will ... Nov 25
China has resorted to rigorous measures after multiple locally transmitted coronavirus cases have been found in three Chinese cities.... Nov 25
Science and Technology Minister Dr. Harsh Vardhan has said that multilateral cooperation is the key to overcoming global challenges such as COVID-19.... Nov 25
The company has experienced an evolving increased presence of Telstar GMP freeze-dryers in China and currently let customers a complete support laboratory service... Nov 24
BHV3000-310 is a double-blind, randomized trial evaluating the safety and efficacy of rimegepant in the acute treatment of migraine.... Nov 23
BNT162b2 is currently in Phase 3 clinical trials in the United States, Germany, Argentina, Brazil, South Africa, Turkey and other countries... Nov 20
Under the agreement, PierianDx will integrate the Pillar Biosciences PiVAT® bioinformatics pipeline in the PierianDx environment to provide users with an accelerated implementation, including assay-... Oct 15
Rhizen and Curon's exclusive license agreement for Tenalisib, a dual PI3K delta & gamma inhibitor in the Greater China region.... Oct 12
Major breakthrough for treatment of Nasopharyngeal Carcinomar ... Sep 11
An emergency use authorisation, which is based on Chinese vaccine management law, allows unapproved vaccine candidates to be used among people who are at high ... Aug 24
A 68-year-old woman in the central Chinese province of Hubei, where the novel coronavirus first surfaced in December, tested positive on Sunday... Aug 17
According to the first phase results, 90 per cent of the patients'lungs are still in a damaged state, which means their lungs ventilation and ... Aug 06
The expansion of partnership is an important step forward in the efforts to develop a safe, effective and globally accessible vaccine against COVID-19... Jul 18
-Advertisements-
Monday, April 29, 2024
.jpeg)
.jpg)
